Cordlife, a regional pioneer in cord blood banking, has been in business for around two decades. CEO Tan Poh Lan believes there is still plenty of growth potential, as the company tries to sign up more customers who are more affluent and aware of the uses of cord blood and cord tissue.
Some of Tan’s nieces, for one, have signed up for the services, but she knows there is a bigger addressable market out there. “Personally, I feel there is a lot of scope and potential use for cord blood, cord tissue and stem cells,” says Tan in a recent interview with The Edge Singapore.
To date, Cordlife has serviced over 550,000 parents through its full stem-cell banking facilities that span across Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. Cordlife has — through its marketing agents — extended its presence to Myanmar and Vietnam in 2017, and Bangladesh in 2019. It is also present in Thailand through an indirect stake in Thai Stemlife — the nation’s largest cord blood bank — which it holds through a Malaysian subsidiary.